osimertinib
astrazeneca
['vela', 'osimertinib']
4. key #asco23 revelation: adjuvant osimertinib significantly improved overall survival (os) in stage ii iiia disease patients. os hr was 0.49 (p=0.0004). advancements are here! #cancersurvivor #cancer 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer